Cargando…

Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product

Coagulation factor IX (FIX) is a complex post-translationally modified human serum glycoprotein and high-value biopharmaceutical. The quality of recombinant FIX (rFIX), especially complete γ-carboxylation, is critical for rFIX clinical efficacy. Bioreactor operating conditions can impact rFIX produc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zacchi, Lucia F., Roche-Recinos, Dinora, Pegg, Cassandra L., Phung, Toan K., Napoli, Mark, Aitken, Campbell, Sandford, Vanessa, Mahler, Stephen M., Lee, Yih Yean, Schulz, Benjamin L., Howard, Christopher B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988164/ https://www.ncbi.nlm.nih.gov/pubmed/33758337 http://dx.doi.org/10.1038/s42003-021-01903-x

Ejemplares similares

GlypNirO: An automated workflow for quantitative N- and O-linked glycoproteomic data analysis
por: Phung, Toan K, et al.
Publicado: (2020)

Coagulation Factor IX for Hemophilia B Therapy 
por: Orlova, N. A., et al.
Publicado: (2012)

Quantitative Data-Independent Acquisition Glycoproteomics of Sparkling Wine
por: Pegg, Cassandra L., et al.
Publicado: (2020)

Degradation of C-terminal tag sequences on domain antibodies purified from E. coli supernatant
por: Lykkemark, Simon, et al.
Publicado: (2014)

Understanding ForteBio’s Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant
por: Yu, Yao, et al.
Publicado: (2016)

Probing activation‐driven changes in coagulation factor IX by mass spectrometry
por: Freato, Nadia, et al.
Publicado: (2021)

The post-translational modification landscape of commercial beers
por: Kerr, Edward D., et al.
Publicado: (2021)

Treatment of the Supernatant of Anaerobically Digested Organic Fraction of Municipal Solid Waste in a Demo-Scale Mesophilic External Anaerobic Membrane Bioreactor
por: Giménez-Lorang, Antonio, et al.
Publicado: (2021)

The first EGF domain of coagulation factor IX attenuates cell adhesion and induces apoptosis
por: Ishikawa, Tomomi, et al.
Publicado: (2016)

Ribosome profiling of HEK293T cells overexpressing codon optimized coagulation factor IX
por: Alexaki, Aikaterini, et al.
Publicado: (2020)

Long-Acting Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Children: Results of a Phase 3 Trial
por: Kenet, Gili, et al.
Publicado: (2016)

Proteomic analysis of post-nuclear supernatant fraction and percoll-purified membranes prepared from brain cortex of rats exposed to increasing doses of morphine
por: Ujcikova, Hana, et al.
Publicado: (2014)

Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyser
por: Okuda, Masahiro, et al.
Publicado: (2003)

Recombinant biosynthesis of functional human growth hormone and coagulation factor IX in transgenic soybean seeds
por: da Cunha, Nicolau Brito, et al.
Publicado: (2014)

Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies
por: Alexaki, Aikaterini, et al.
Publicado: (2019)

Fusion of engineered albumin with factor IX Padua extends half‐life and improves coagulant activity
por: Lombardi, Silvia, et al.
Publicado: (2021)

Coagulation factors II, V, VII, IX, X and XI and mortality – a cohort study
por: Yap, Eng Soo, et al.
Publicado: (2023)

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023)

Targeting of the Human Coagulation Factor IX Gene at rDNA Locus of Human Embryonic Stem Cells
por: Liu, Xionghao, et al.
Publicado: (2012)

Development of Methods for the Selective Measurement of the Single Amino Acid Exchange Variant Coagulation Factor IX Padua
por: Weber, Alfred, et al.
Publicado: (2018)

Maturation of coagulation factor IX during Xase formation as deduced using factor VIII‐derived peptides
por: Fang, Han, et al.
Publicado: (2019)

Effects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity
por: Zhao, Ying, et al.
Publicado: (2017)

Preclinical evaluation of a next-generation, subcutaneously administered, coagulation factor IX variant, dalcinonacog alfa
por: Nichols, Timothy C., et al.
Publicado: (2020)

THE ANTIPROTEOLYTIC ACTIVITY OF SERUM : II. PHYSIOLOGICAL SIGNIFICANCE. THE INFLUENCE OF PURIFIED TRYPSIN INHIBITOR ON THE COAGULATION OF THE BLOOD
por: Grob, David
Publicado: (1943)

Enhancement of pulmonary tumour seeding by human coagulation factors II, IX, X--an investigation into the possible mechanisms involved.
por: Purushotham, A. D., et al.
Publicado: (1991)

Acquired Inhibitors to Multiple Coagulation Factors (V, IX, and XII) Identified in a Unique Patient with Hepatocellular Carcinoma
por: Imataki, Osamu, et al.
Publicado: (2017)

Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria
por: Chen, Jinwu, et al.
Publicado: (2019)

Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease)
por: Larson, Emily A., et al.
Publicado: (2021)

Impact of Coagulant and Flocculant Addition to an Anaerobic Dynamic Membrane Bioreactor (AnDMBR) Treating Waste-Activated Sludge
por: Kooijman, Guido, et al.
Publicado: (2017)

Development of a Short-Cut Combined Magnetic Coagulation–Sequence Batch Membrane Bioreactor for Swine Wastewater Treatment
por: Chen, Yanlin, et al.
Publicado: (2021)

IDEAL study: A real‐world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX‐FP) in patients with haemophilia B in Italy
por: Tagliaferri, Annarita, et al.
Publicado: (2022)

Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling
por: Müller, Elisabeth, et al.
Publicado: (2014)

Compensated pathogenic variants in coagulation factors VIII and IX present complex mapping between molecular impact and hemophilia severity
por: Marín, Òscar, et al.
Publicado: (2019)

Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one‐stage clotting assays
por: Horn, C., et al.
Publicado: (2018)

Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence
por: Carpintero-Fernández, Paula, et al.
Publicado: (2022)

The Pro-Coagulant Fibrinogenolytic Serine Protease Isoenzymes Purified from Daboia russelii russelii Venom Coagulate the Blood through Factor V Activation: Role of Glycosylation on Enzymatic Activity
por: Mukherjee, Ashis K.
Publicado: (2014)

CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse
por: Guan, Yuting, et al.
Publicado: (2016)

Half-life–extended recombinant coagulation factor IX–albumin fusion protein is recycled via the FcRn-mediated pathway
por: Chia, Jenny, et al.
Publicado: (2018)

Genes IX /
por: Lewin, Benjamin
Publicado: (2008)

Genes IX /
por: Lewin, Benjamin
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4r79mb2u0q4cdc3bglqnk31mr5